114 related articles for article (PubMed ID: 26783407)
1. Qingyihuaji Formula Inhibits Pancreatic Cancer and Prolongs Survival by Downregulating Hes-1 and Hey-1.
Xu Y; Xu S; Cai Y; Liu L
Evid Based Complement Alternat Med; 2015; 2015():145016. PubMed ID: 26783407
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor effect of the extract from qingyihuaji formula on pancreatic cancer by down-regulating Notch-4 and Jagged-1.
Xu Y; Zhu F; Xu S; Liu L
J Tradit Chin Med; 2015 Feb; 35(1):77-83. PubMed ID: 25842732
[TBL] [Abstract][Full Text] [Related]
3. Qingyihuaji formula reverses gemcitabine resistant human pancreatic cancer through regulate lncRNA AB209630/miR-373/EphB2-NANOG signals.
Chen P; Wang M; Wang C
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31147453
[TBL] [Abstract][Full Text] [Related]
4. Ski acts as therapeutic target of qingyihuaji formula in the treatment of SW1990 pancreatic cancer.
Wang P; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Shen YH; Liu LM
Integr Cancer Ther; 2010 Mar; 9(1):50-8. PubMed ID: 20308085
[TBL] [Abstract][Full Text] [Related]
5. Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenograft by targeting to decrease expression of Cyr61 and VEGF.
Yin JH; Shi WD; Zhu XY; Chen Z; Liu LM
Integr Cancer Ther; 2012 Mar; 11(1):37-47. PubMed ID: 21382954
[TBL] [Abstract][Full Text] [Related]
6. Qingyihuaji Formula promotes apoptosis and autophagy through inhibition of MAPK/ERK and PI3K/Akt/mTOR signaling pathway on pancreatic cancer in vivo and in vitro.
Qian X; Bi QY; Wang ZN; Han F; Liu LM; Song LB; Li CY; Zhang AQ; Ji XM
J Ethnopharmacol; 2023 May; 307():116198. PubMed ID: 36690307
[TBL] [Abstract][Full Text] [Related]
7. High expression of erythropoietin-producing hepatoma cell line-B2 (EphB2) predicts the efficiency of the Qingyihuaji formula treatment in pancreatic cancer CFPAC-1 cells through the EphrinB1-EphB2 pathway.
Hua YQ; Chen Z; Meng ZQ; Chen H; Shen JG; Wang K; Peng W; Shen YH; Liu LM
Oncol Lett; 2014 Jul; 8(1):17-24. PubMed ID: 24959213
[TBL] [Abstract][Full Text] [Related]
8. Nanog Predicts Poor Prognosis in Human Pancreatic Cancer and Is Downregulated by QingyihuaJi Formula in Pancreatic Cancer Stem Cells.
Gao S; Pan Y; Song L; Dong L; Weng LI; Wang P; Hua Y; Chen Z; Liu L
Evid Based Complement Alternat Med; 2016; 2016():7028289. PubMed ID: 27829864
[TBL] [Abstract][Full Text] [Related]
9. Retracted: Qingyihuaji Formula Inhibits Pancreatic Cancer and Prolongs Survival by Downregulating Hes-1 and Hey-1.
Alternative Medicine ECA
Evid Based Complement Alternat Med; 2021; 2021():8230693. PubMed ID: 33727942
[TBL] [Abstract][Full Text] [Related]
10. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
Bi YL; Min M; Shen W; Liu Y
Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
[TBL] [Abstract][Full Text] [Related]
11. Targeting cancer-related inflammation: Chinese herbal medicine inhibits epithelial-to-mesenchymal transition in pancreatic cancer.
Zhang J; Wang P; Ouyang H; Yin J; Liu A; Ma C; Liu L
PLoS One; 2013; 8(7):e70334. PubMed ID: 23922983
[TBL] [Abstract][Full Text] [Related]
12. [Effect of Qingyi Huaji formula for inhibition of pancreatic cancer cell growth through down-regulating Ski expression].
Wang P; Liu LM; Chen Z
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Sep; 30(9):942-5. PubMed ID: 21179734
[TBL] [Abstract][Full Text] [Related]
13. Effects of Qingyi Huaji decoction on serum levels of interleukin-6, interleukin-8 and tumor necrosis factor-alpha in nude mice bearing pancreatic tumors.
Ouyang HQ; Liu LM; Chen Z; Luo JM; Yu EX
Zhong Xi Yi Jie He Xue Bao; 2010 Jul; 8(7):655-61. PubMed ID: 20619142
[TBL] [Abstract][Full Text] [Related]
14. Effects of baicalein on pancreatic cancer stem cells via modulation of sonic Hedgehog pathway.
Song L; Chen X; Wang P; Gao S; Qu C; Liu L
Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):586-596. PubMed ID: 29697746
[TBL] [Abstract][Full Text] [Related]
15. Babaodan Capsule () combined with Qingyi Huaji Formula () in advanced pancreatic cancer-a feasibility study.
Song LB; Gao S; Zhang AQ; Qian X; Liu LM
Chin J Integr Med; 2017 Dec; 23(12):937-942. PubMed ID: 28664246
[TBL] [Abstract][Full Text] [Related]
16. Integrated Analyses Identify Immune-Related Signature Associated with Qingyihuaji Formula for Treatment of Pancreatic Ductal Adenocarcinoma Using Network Pharmacology and Weighted Gene Co-Expression Network.
Qian X; Chen Z; Chen SS; Liu LM; Zhang AQ
J Immunol Res; 2020; 2020():7503605. PubMed ID: 32537471
[TBL] [Abstract][Full Text] [Related]
17. Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer.
Katoh M; Katoh M
Int J Oncol; 2007 Aug; 31(2):461-6. PubMed ID: 17611704
[TBL] [Abstract][Full Text] [Related]
18. Cooperative functions of Hes/Hey genes in auditory hair cell and supporting cell development.
Tateya T; Imayoshi I; Tateya I; Ito J; Kageyama R
Dev Biol; 2011 Apr; 352(2):329-40. PubMed ID: 21300049
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of Hes/Hey genes during inner ear development.
Petrovic J; Gálvez H; Neves J; Abelló G; Giraldez F
Dev Neurobiol; 2015 Jul; 75(7):703-20. PubMed ID: 25363712
[TBL] [Abstract][Full Text] [Related]
20. Dihydrosanguinarine suppresses pancreatic cancer cells via regulation of mut-p53/WT-p53 and the Ras/Raf/Mek/Erk pathway.
Wu SZ; Xu HC; Wu XL; Liu P; Shi YC; Pang P; Deng L; Zhou GX; Chen XY
Phytomedicine; 2019 Jun; 59():152895. PubMed ID: 30913453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
